The Cancer and Stem Cell Biology (CSCB) Program Area was established in 2010, in response to increasing evidence that the concepts and tools of stem cell biology can be used to gain new insights into cancer biology, and to take advantage of the tremendous expansion and productivity of the stem cell research community at UCLA. The primary goal of the CSCB Program Area is to link basic and translational investigators interested in the unique biological processes shared by malignancy and stem cells. The fundamental biology that characterizes these two fields can be viewed as the control of the opposing processes of self-renewal and differentiation. The balance of these processes is, in turn, determined by cell intrinsic and micro-environmental cues. These common mechanisms are studied by CSCB investigators using normal stem cells and their malignant counterparts from two experimental platforms: Hematopoiesis and Epithelium. Similarly, clinical research projects in CSCB focus predominantly on hematologic and genitourinary malignancies. Scientific interactions between the two platforms are driven by three main integrating themes that are relevant to the study of malignancy and stem cell biology irrespective of the specific tissue/cell source: 1) the regulation of growth and differentiation in tissue-specific stem cells during malignant transformation and normal development;2) the role of microenvironment in tumor formation and stem cell regulation;3) the use of pluripotent stem cells as a model to study basic mechanisms of self-renewal and transformation. The CSCB Program Area is comprised of 31 members, representing three schools and twelve departments;six members are

Public Health Relevance

The CSCB Program Area is structured to optimize multidisciplinary investigations in the broad areas of cancer and stem cell biology. By linking basic and translational investigators interested in these complementary fields, novel mechanisms involved in malignancy are uncovered and previously untapped targets for therapeutic development are revealed. The intellectual wealth of stem cell biology research at UCLA combined with the extensive interactions of physicians and scientists within the CSCB Program Area provide a highly productive and collaborative environment for basic and translational research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-39
Application #
8635432
Study Section
Subcommittee G - Education (NCI)
Project Start
1996-12-01
Project End
2018-11-30
Budget Start
2014-03-07
Budget End
2014-11-30
Support Year
39
Fiscal Year
2014
Total Cost
$27,084
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Wu, Sheng; Wong, Weng Kee; Crespi, Catherine M (2017) Maximin optimal designs for cluster randomized trials. Biometrics 73:916-926
Douaisi, Marc; Resop, Rachel S; Nagasawa, Maho et al. (2017) CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus. J Immunol 198:2310-2319
Qi, Hangfei; Chu, Virginia; Wu, Nicholas C et al. (2017) Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein. Proc Natl Acad Sci U S A 114:2018-2023
Lu, Jianqin; Liu, Xiangsheng; Liao, Yu-Pei et al. (2017) Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nat Commun 8:1811
Castaneda, Julie T; Harui, Airi; Roth, Michael D (2017) Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation. J Neuroimmune Pharmacol 12:544-554
Casillas, Jacqueline; Goyal, Anju; Bryman, Jason et al. (2017) Development of a text messaging system to improve receipt of survivorship care in adolescent and young adult survivors of childhood cancer. J Cancer Surviv 11:505-516
Su, Yapeng; Wei, Wei; Robert, Lidia et al. (2017) Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance. Proc Natl Acad Sci U S A 114:13679-13684
Demer, Linda L; Tintut, Yin; Nguyen, Kim-Lien et al. (2017) Rigor and Reproducibility in Analysis of Vascular Calcification. Circ Res 120:1240-1242
Kiyohara, M H; Dillard, C; Tsui, J et al. (2017) EMP2 is a novel therapeutic target for endometrial cancer stem cells. Oncogene 36:5793-5807
Dock, Jeffrey; Ramirez, Christina M; Hultin, Lance et al. (2017) Distinct aging profiles of CD8+ T cells in blood versus gastrointestinal mucosal compartments. PLoS One 12:e0182498

Showing the most recent 10 out of 721 publications